Phenylketonuria: Tyrosine beyond the phenylalanine-restricted diet

Journal of Inherited Metabolic Disease

Volumn 24, Issue 1, 2001, Pages 1-4

  Van Spronsen, F J ^a   Smit, P G A ^a   Koch, R ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; TYROSINE;

ADULT; AGE; AMINO ACID TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HUMAN; PATHOGENESIS; PHENYLKETONURIA;

AMINO ACIDS, NEUTRAL; BLOOD-BRAIN BARRIER; HUMANS; NEUROTRANSMITTER AGENTS; PHENYLALANINE; PHENYLKETONURIAS; PREFRONTAL CORTEX; TYROSINE;

EID: 0035100372     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005689232358     Document Type: Article

References (25)

1. Unsuccessful treatment of phenylketonuria with tyrosine
2. Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine
3. Valine, isoleucine and leucine. A new treatment for phenylketonuria
4. Genetic failure of fetal amino acid 'justification': A common basis for many forms of metabolic, nutritional, and 'nonspecific' mental retardation
5. Historical perspective: Tyrosine and maternal phenylketonuria, welcome news
6. Evidence for the importance of dopamine for prefrontal cortex functions early in life
7. Tyrosine supplementation for phenylketonuria treatment
8. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies
9. Tyrosine supplementation during pregnancy in a woman with classical phenylketonuria. A case report
10. Neuropsychological and neuroradiological (MRI) variations during phenylalanine load: Protective effect of valine, leucine and isoleucine supplementation
11. Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria
12. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents
13. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria
14. Cognition and tyrosine supplementation among school-aged children with phenylketonuria
15. The effect of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain
16. Neurotransmitter positron emission tomographic studies in adults with phenylketonuria, a pilot study
17. Neuropsychological deficits in early treated phenylketonuric children
18. Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria
19. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
20. The hyperphenylalaninemias
21. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria
22. Effects of L-DOPA on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria
23. PKU treatment beyond childhood. The use of positron emission tomography (PET) to design a well-balanced treatment
24. Neuropsychology of early-treated phenylketonuria: Specific executive function deficits